07/01/2024
Research Article
Direct factor Xa inhibitors and the risk of cancer and cancer mortality: A Danish population-based cohort study
Floris Bosch and colleagues investigate whether patients with atrial fibrillation taking direct Factor Xa inhibitors have a lower risk of cancer and cancer-related mortality than patients taking dabigatran.
Image credit: Pexels, Pixabay
Connect with Us